"Ośrodek Badań Klinicznych"

During the past decade, IRMED Osrodek Badan Klinicznych conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRMED Osrodek Badan Klinicznych" #1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "IRMED Osrodek Badan Klinicznych" are "Atopic Dermatitis" (1 trials), "Crohn's Disease" (1 trials), "Influenza" (1 trials), "Menopausal Symptoms" (1 trials) and "Vasomotor Symptoms" (1 trials). Many other conditions were trialed in "IRMED Osrodek Badan Klinicznych" in a lesser frequency.

Most popular intervention types in "IRMED Osrodek Badan Klinicznych" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Baloxavir Marboxil" (1 trials), "Estetrol oral tablet" (1 trials), "PF-04965842" (1 trials) and "PF-06651600" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRMED Osrodek Badan Klinicznych" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "IRMED Osrodek Badan Klinicznych". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in IRMED Osrodek Badan Klinicznych, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRMED Osrodek Badan Klinicznych, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".